All News #Library
Biotech
Engeneic Doses First Patient In Recurrent Glioblastoma Trial
30 Apr 2026 //
FIRSTWORD PHARMA
EnGeneIC publishes the COVID-EDV vaccine"s novel mechanism of action
31 Jan 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support